Quinonoid and phenazine compounds: synthesis and evaluation against H37Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis

Eur J Med Chem. 2011 Sep;46(9):4521-9. doi: 10.1016/j.ejmech.2011.07.026. Epub 2011 Jul 23.

Abstract

Several quinonoid and phenazine compounds were synthesized in moderate to high yields and showed activity against H(37)Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis. The cytotoxity of the compounds were evaluated against human peripheral blood mononuclear cells (PBMC) and these substances emerge as promising antitubercular prototypes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / chemical synthesis*
  • Antitubercular Agents / chemistry
  • Antitubercular Agents / pharmacology*
  • Cells, Cultured
  • Drug Resistance, Microbial
  • Isoniazid / pharmacology
  • Magnetic Resonance Spectroscopy
  • Microbial Sensitivity Tests
  • Models, Molecular
  • Mycobacterium tuberculosis / drug effects*
  • Phenazines / chemical synthesis*
  • Phenazines / chemistry
  • Phenazines / pharmacology
  • Quinones / chemical synthesis*
  • Quinones / chemistry
  • Quinones / pharmacology
  • Rifampin / pharmacology
  • Spectrometry, Mass, Electrospray Ionization
  • Spectrophotometry, Infrared
  • X-Ray Diffraction

Substances

  • Antitubercular Agents
  • Phenazines
  • Quinones
  • Isoniazid
  • Rifampin